Kyle Piskel Adaptive Biotechnologies Corp (ADPT) insider trading activity

Kyle Piskel is Chief Financial Officer of Adaptive Biotechnologies Corp. Currently has a direct ownership of 216,637 shares of ADPT, which is worth approximately $3.05 Million. The most recent transaction as insider was on Nov 28, 2025, when has been sold 162,820 shares (Common Stock) at a price of $19.5 per share, resulting in proceeds of $3,174,990. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 217K

21.9% 3M change

40.37% 12M change

Total Value Held $3.05 Million

KYLE PISKEL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 28 2025	SELL Open market or private sale	$3,174,990 $19.5 p/Share	162,820 Reduced 42.91%	216,637 Common Stock
Nov 28 2025	BUY Exercise of conversion of derivative security	$972,306 $8.83 p/Share	110,114 Added 22.49%	379,457 Common Stock
Nov 17 2025	SELL Open market or private sale	$3,343 $14.05 p/Share	238 Reduced 0.09%	269,343 Common Stock
May 16 2025	SELL Open market or private sale	$17,148 $8.89 p/Share	1,929 Reduced 0.69%	277,396 Common Stock
May 15 2025	BUY Grant, award, or other acquisition	-	7,815 Added 2.72%	279,325 Common Stock
Mar 14 2025	BUY Exercise of conversion of derivative security	$15,800 $6.32 p/Share	2,500 Added 0.91%	271,510 Common Stock
Mar 05 2025	SELL Open market or private sale	$72,033 $6.98 p/Share	10,320 Reduced 3.69%	269,010 Common Stock

Mar 04 2025	BUY Grant, award, or other acquisition	-	125,000 Added 30.92%	279,330 Common Stock
Nov 18 2024	SELL Open market or private sale	$1,235 $4.98 p/Share	248 Reduced 0.16%	154,330 Common Stock
May 15 2024	BUY Grant, award, or other acquisition	-	31,260 Added 16.82%	154,578 Common Stock
Mar 05 2024	SELL Open market or private sale	$26,503 $3.43 p/Share	7,727 Reduced 5.9%	123,318 Common Stock
Mar 04 2024	BUY Grant, award, or other acquisition	-	43,740 Added 25.03%	131,045 Common Stock
Nov 16 2023	SELL Open market or private sale	$1,069 $4.13 p/Share	259 Reduced 0.3%	87,305 Common Stock
Mar 06 2023	SELL Open market or private sale	$30,278 $8.58 p/Share	3,529 Reduced 3.87%	87,564 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	43,735 Added 32.44%	91,093 Common Stock
Nov 16 2022	SELL Open market or private sale	$8,506 $8.87 p/Share	959 Reduced 2.01%	46,706 Common Stock
Mar 07 2022	SELL Open market or private sale	$2,642 $12.01 p/Share	220 Reduced 0.46%	47,665 Common Stock
Mar 04 2022	BUY Grant, award, or other acquisition	-	41,186 Added 46.24%	47,885 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	3,837 Added 36.42%	6,699 Common Stock

Kyle Piskel

Chief Financial Officer

Seattle, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Value

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT

Account